Viewing Study NCT00661492


Ignite Creation Date: 2025-12-24 @ 3:34 PM
Ignite Modification Date: 2026-02-24 @ 3:16 PM
Study NCT ID: NCT00661492
Status: COMPLETED
Last Update Posted: 2016-12-09
First Post: 2008-04-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
Sponsor: US Oncology Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Androgen-independent Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Androgen-independent prostate cancer(AIPC) View